Reprogrammed cells for disease modeling and regenerative medicine
Anne B C Cherry1, George Q Daley
1Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Manton Center for Orphan Disease Research, Howard Hughes Medical Institute, Boston, MA, USA.
Annual Review of Medicine
|January 19, 2013
Summary
Induced pluripotent stem (iPS) cells offer new ways to study and treat diseases, especially blood disorders. Researchers are comparing iPS cells to embryonic stem cells and identifying challenges for future clinical applications.
Area of Science:
- Biomedical research
- Stem cell biology
- Hematology
Background:
- Somatic cell reprogramming into induced pluripotent stem (iPS) cells is revolutionizing disease research and treatment.
- Hematopoietic stem cell transplantation is a well-established clinical procedure.
- iPS cells hold significant potential for advancing hematology.
Purpose of the Study:
- To compare induced pluripotent stem cells (iPSCs) with embryonic stem cells (ESCs).
- To review the progress in modeling hematological disorders using iPSCs.
- To identify obstacles for the clinical implementation of iPS cell therapies.
Main Methods:
- Comparative analysis of iPSCs and ESCs.
- Review of current literature on iPSC-based hematological disorder modeling.
- Identification and discussion of challenges in iPS cell therapy development.
Main Results:
- iPSCs and ESCs share many similarities, but differences exist.
- Significant progress has been made in modeling various blood disorders using patient-derived iPSCs.
- Key challenges remain in ensuring safety, efficacy, and scalability for clinical translation.
Conclusions:
- iPS cells represent a promising tool for hematology research and potentially for therapeutic applications.
- Overcoming current technical and safety hurdles is crucial for realizing the clinical potential of iPS cell therapies in treating blood disorders.
More Related Videos
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...